The randomized placebo-phase design for clinical trials (Q48867556)

16 February 2018

title

The randomized placebo-phase design for clinical trials (English)

1 reference

16 February 2018

1 reference

Feldman B

1

1 reference

16 February 2018

Wang E

series ordinal

2

1 reference

16 February 2018

Willan A

series ordinal

3

1 reference

16 February 2018

Szalai JP

series ordinal

4

1 reference

16 February 2018

publication date

1 June 2001

1 reference

16 February 2018

Journal of Clinical Epidemiology

published in

1 reference

16 February 2018

volume

54

1 reference

16 February 2018

issue

6

1 reference

16 February 2018

page(s)

550-557

1 reference

16 February 2018

Accrual to cancer clinical trials: directions from the research literature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

The ethics of the randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Reasons for non-entry in randomized clinical trials for breast cancer: a single institutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

The two-period cross-over clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Combined single subject trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Randomizing responders. Cardiac Arrhythmia Suppression Trial (CAST) investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

Power and sample size calculations. A review and computer program

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900357-7

7 January 2021

10.1016/S0895-4356(00)00357-7

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018